Global Nonstructural Protein 4B Market Growth (Status and Outlook) 2025-2031

October 2025 | 73 pages | ID: G47A07C4ADFCEN
LP Information

Abstracts

According to this study, the global Nonstructural Protein 4B market size will reach US$ million by 2031.

United States market for Nonstructural Protein 4B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nonstructural Protein 4B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nonstructural Protein 4B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nonstructural Protein 4B players cover Gilead Sciences, Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the ?Nonstructural Protein 4B Industry Forecast? looks at past sales and reviews total world Nonstructural Protein 4B sales in 2024, providing a comprehensive analysis by region and market sector of projected Nonstructural Protein 4B sales for 2025 through 2031. With Nonstructural Protein 4B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nonstructural Protein 4B industry.

This Insight Report provides a comprehensive analysis of the global Nonstructural Protein 4B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nonstructural Protein 4B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nonstructural Protein 4B market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nonstructural Protein 4B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nonstructural Protein 4B.

This report presents a comprehensive overview, market shares, and growth opportunities of Nonstructural Protein 4B market by product type, application, key players and key regions and countries.

Segmentation by Type:

• INO-8000
• GSK-8853
• PTC-725
• RL-15A
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Gilead Sciences, Inc.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals, Inc.
• Johnson & Johnson
• Merck & Co., Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nonstructural Protein 4B Market Size (2020-2031)
  2.1.2 Nonstructural Protein 4B Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Nonstructural Protein 4B by Country/Region (2020, 2024 & 2031)
2.2 Nonstructural Protein 4B Segment by Type
  2.2.1 INO-8000
  2.2.2 GSK-8853
  2.2.3 PTC-725
  2.2.4 RL-15A
  2.2.5 Others
2.3 Nonstructural Protein 4B Market Size by Type
  2.3.1 Nonstructural Protein 4B Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Nonstructural Protein 4B Market Size Market Share by Type (2020-2025)
2.4 Nonstructural Protein 4B Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Nonstructural Protein 4B Market Size by Application
  2.5.1 Nonstructural Protein 4B Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Nonstructural Protein 4B Market Size Market Share by Application (2020-2025)

3 NONSTRUCTURAL PROTEIN 4B MARKET SIZE BY PLAYER

3.1 Nonstructural Protein 4B Market Size Market Share by Player
  3.1.1 Global Nonstructural Protein 4B Revenue by Player (2020-2025)
  3.1.2 Global Nonstructural Protein 4B Revenue Market Share by Player (2020-2025)
3.2 Global Nonstructural Protein 4B Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NONSTRUCTURAL PROTEIN 4B BY REGION

4.1 Nonstructural Protein 4B Market Size by Region (2020-2025)
4.2 Global Nonstructural Protein 4B Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nonstructural Protein 4B Market Size Growth (2020-2025)
4.4 APAC Nonstructural Protein 4B Market Size Growth (2020-2025)
4.5 Europe Nonstructural Protein 4B Market Size Growth (2020-2025)
4.6 Middle East & Africa Nonstructural Protein 4B Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Nonstructural Protein 4B Market Size by Country (2020-2025)
5.2 Americas Nonstructural Protein 4B Market Size by Type (2020-2025)
5.3 Americas Nonstructural Protein 4B Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nonstructural Protein 4B Market Size by Region (2020-2025)
6.2 APAC Nonstructural Protein 4B Market Size by Type (2020-2025)
6.3 APAC Nonstructural Protein 4B Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Nonstructural Protein 4B Market Size by Country (2020-2025)
7.2 Europe Nonstructural Protein 4B Market Size by Type (2020-2025)
7.3 Europe Nonstructural Protein 4B Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nonstructural Protein 4B by Region (2020-2025)
8.2 Middle East & Africa Nonstructural Protein 4B Market Size by Type (2020-2025)
8.3 Middle East & Africa Nonstructural Protein 4B Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NONSTRUCTURAL PROTEIN 4B MARKET FORECAST

10.1 Global Nonstructural Protein 4B Forecast by Region (2026-2031)
  10.1.1 Global Nonstructural Protein 4B Forecast by Region (2026-2031)
  10.1.2 Americas Nonstructural Protein 4B Forecast
  10.1.3 APAC Nonstructural Protein 4B Forecast
  10.1.4 Europe Nonstructural Protein 4B Forecast
  10.1.5 Middle East & Africa Nonstructural Protein 4B Forecast
10.2 Americas Nonstructural Protein 4B Forecast by Country (2026-2031)
  10.2.1 United States Market Nonstructural Protein 4B Forecast
  10.2.2 Canada Market Nonstructural Protein 4B Forecast
  10.2.3 Mexico Market Nonstructural Protein 4B Forecast
  10.2.4 Brazil Market Nonstructural Protein 4B Forecast
10.3 APAC Nonstructural Protein 4B Forecast by Region (2026-2031)
  10.3.1 China Nonstructural Protein 4B Market Forecast
  10.3.2 Japan Market Nonstructural Protein 4B Forecast
  10.3.3 Korea Market Nonstructural Protein 4B Forecast
  10.3.4 Southeast Asia Market Nonstructural Protein 4B Forecast
  10.3.5 India Market Nonstructural Protein 4B Forecast
  10.3.6 Australia Market Nonstructural Protein 4B Forecast
10.4 Europe Nonstructural Protein 4B Forecast by Country (2026-2031)
  10.4.1 Germany Market Nonstructural Protein 4B Forecast
  10.4.2 France Market Nonstructural Protein 4B Forecast
  10.4.3 UK Market Nonstructural Protein 4B Forecast
  10.4.4 Italy Market Nonstructural Protein 4B Forecast
  10.4.5 Russia Market Nonstructural Protein 4B Forecast
10.5 Middle East & Africa Nonstructural Protein 4B Forecast by Region (2026-2031)
  10.5.1 Egypt Market Nonstructural Protein 4B Forecast
  10.5.2 South Africa Market Nonstructural Protein 4B Forecast
  10.5.3 Israel Market Nonstructural Protein 4B Forecast
  10.5.4 Turkey Market Nonstructural Protein 4B Forecast
10.6 Global Nonstructural Protein 4B Forecast by Type (2026-2031)
10.7 Global Nonstructural Protein 4B Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Nonstructural Protein 4B Forecast

11 KEY PLAYERS ANALYSIS

11.1 Gilead Sciences, Inc.
  11.1.1 Gilead Sciences, Inc. Company Information
  11.1.2 Gilead Sciences, Inc. Nonstructural Protein 4B Product Offered
  11.1.3 Gilead Sciences, Inc. Nonstructural Protein 4B Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Gilead Sciences, Inc. Main Business Overview
  11.1.5 Gilead Sciences, Inc. Latest Developments
11.2 GlaxoSmithKline Plc
  11.2.1 GlaxoSmithKline Plc Company Information
  11.2.2 GlaxoSmithKline Plc Nonstructural Protein 4B Product Offered
  11.2.3 GlaxoSmithKline Plc Nonstructural Protein 4B Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GlaxoSmithKline Plc Main Business Overview
  11.2.5 GlaxoSmithKline Plc Latest Developments
11.3 Inovio Pharmaceuticals, Inc.
  11.3.1 Inovio Pharmaceuticals, Inc. Company Information
  11.3.2 Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Product Offered
  11.3.3 Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Inovio Pharmaceuticals, Inc. Main Business Overview
  11.3.5 Inovio Pharmaceuticals, Inc. Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Nonstructural Protein 4B Product Offered
  11.4.3 Johnson & Johnson Nonstructural Protein 4B Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments
11.5 Merck & Co., Inc.
  11.5.1 Merck & Co., Inc. Company Information
  11.5.2 Merck & Co., Inc. Nonstructural Protein 4B Product Offered
  11.5.3 Merck & Co., Inc. Nonstructural Protein 4B Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Merck & Co., Inc. Main Business Overview
  11.5.5 Merck & Co., Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nonstructural Protein 4B Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nonstructural Protein 4B Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of INO-8000
Table 4. Major Players of GSK-8853
Table 5. Major Players of PTC-725
Table 6. Major Players of RL-15A
Table 7. Major Players of Others
Table 8. Nonstructural Protein 4B Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nonstructural Protein 4B Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Nonstructural Protein 4B Market Size Market Share by Type (2020-2025)
Table 11. Nonstructural Protein 4B Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Nonstructural Protein 4B Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Nonstructural Protein 4B Market Size Market Share by Application (2020-2025)
Table 14. Global Nonstructural Protein 4B Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Nonstructural Protein 4B Revenue Market Share by Player (2020-2025)
Table 16. Nonstructural Protein 4B Key Players Head office and Products Offered
Table 17. Nonstructural Protein 4B Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nonstructural Protein 4B Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Nonstructural Protein 4B Market Size Market Share by Region (2020-2025)
Table 22. Global Nonstructural Protein 4B Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Nonstructural Protein 4B Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Nonstructural Protein 4B Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Nonstructural Protein 4B Market Size Market Share by Country (2020-2025)
Table 26. Americas Nonstructural Protein 4B Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Nonstructural Protein 4B Market Size Market Share by Type (2020-2025)
Table 28. Americas Nonstructural Protein 4B Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Nonstructural Protein 4B Market Size Market Share by Application (2020-2025)
Table 30. APAC Nonstructural Protein 4B Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Nonstructural Protein 4B Market Size Market Share by Region (2020-2025)
Table 32. APAC Nonstructural Protein 4B Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Nonstructural Protein 4B Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Nonstructural Protein 4B Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Nonstructural Protein 4B Market Size Market Share by Country (2020-2025)
Table 36. Europe Nonstructural Protein 4B Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Nonstructural Protein 4B Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nonstructural Protein 4B Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Nonstructural Protein 4B Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Nonstructural Protein 4B Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nonstructural Protein 4B
Table 42. Key Market Challenges & Risks of Nonstructural Protein 4B
Table 43. Key Industry Trends of Nonstructural Protein 4B
Table 44. Global Nonstructural Protein 4B Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Nonstructural Protein 4B Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Nonstructural Protein 4B Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Nonstructural Protein 4B Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Gilead Sciences, Inc. Details, Company Type, Nonstructural Protein 4B Area Served and Its Competitors
Table 49. Gilead Sciences, Inc. Nonstructural Protein 4B Product Offered
Table 50. Gilead Sciences, Inc. Nonstructural Protein 4B Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Gilead Sciences, Inc. Main Business
Table 52. Gilead Sciences, Inc. Latest Developments
Table 53. GlaxoSmithKline Plc Details, Company Type, Nonstructural Protein 4B Area Served and Its Competitors
Table 54. GlaxoSmithKline Plc Nonstructural Protein 4B Product Offered
Table 55. GlaxoSmithKline Plc Nonstructural Protein 4B Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. GlaxoSmithKline Plc Main Business
Table 57. GlaxoSmithKline Plc Latest Developments
Table 58. Inovio Pharmaceuticals, Inc. Details, Company Type, Nonstructural Protein 4B Area Served and Its Competitors
Table 59. Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Product Offered
Table 60. Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Inovio Pharmaceuticals, Inc. Main Business
Table 62. Inovio Pharmaceuticals, Inc. Latest Developments
Table 63. Johnson & Johnson Details, Company Type, Nonstructural Protein 4B Area Served and Its Competitors
Table 64. Johnson & Johnson Nonstructural Protein 4B Product Offered
Table 65. Johnson & Johnson Nonstructural Protein 4B Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Johnson & Johnson Main Business
Table 67. Johnson & Johnson Latest Developments
Table 68. Merck & Co., Inc. Details, Company Type, Nonstructural Protein 4B Area Served and Its Competitors
Table 69. Merck & Co., Inc. Nonstructural Protein 4B Product Offered
Table 70. Merck & Co., Inc. Nonstructural Protein 4B Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Merck & Co., Inc. Main Business
Table 72. Merck & Co., Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Nonstructural Protein 4B Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonstructural Protein 4B Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nonstructural Protein 4B Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nonstructural Protein 4B Sales Market Share by Country/Region (2024)
Figure 8. Nonstructural Protein 4B Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nonstructural Protein 4B Market Size Market Share by Type in 2024
Figure 10. Nonstructural Protein 4B in Hospital
Figure 11. Global Nonstructural Protein 4B Market: Hospital (2020-2025) & ($ millions)
Figure 12. Nonstructural Protein 4B in Clinic
Figure 13. Global Nonstructural Protein 4B Market: Clinic (2020-2025) & ($ millions)
Figure 14. Nonstructural Protein 4B in Others
Figure 15. Global Nonstructural Protein 4B Market: Others (2020-2025) & ($ millions)
Figure 16. Global Nonstructural Protein 4B Market Size Market Share by Application in 2024
Figure 17. Global Nonstructural Protein 4B Revenue Market Share by Player in 2024
Figure 18. Global Nonstructural Protein 4B Market Size Market Share by Region (2020-2025)
Figure 19. Americas Nonstructural Protein 4B Market Size 2020-2025 ($ millions)
Figure 20. APAC Nonstructural Protein 4B Market Size 2020-2025 ($ millions)
Figure 21. Europe Nonstructural Protein 4B Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Nonstructural Protein 4B Market Size 2020-2025 ($ millions)
Figure 23. Americas Nonstructural Protein 4B Value Market Share by Country in 2024
Figure 24. United States Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Nonstructural Protein 4B Market Size Market Share by Region in 2024
Figure 29. APAC Nonstructural Protein 4B Market Size Market Share by Type (2020-2025)
Figure 30. APAC Nonstructural Protein 4B Market Size Market Share by Application (2020-2025)
Figure 31. China Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 35. India Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Nonstructural Protein 4B Market Size Market Share by Country in 2024
Figure 38. Europe Nonstructural Protein 4B Market Size Market Share by Type (2020-2025)
Figure 39. Europe Nonstructural Protein 4B Market Size Market Share by Application (2020-2025)
Figure 40. Germany Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 41. France Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Nonstructural Protein 4B Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Nonstructural Protein 4B Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Nonstructural Protein 4B Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Nonstructural Protein 4B Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 54. APAC Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 55. Europe Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 57. United States Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 58. Canada Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 59. Mexico Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 60. Brazil Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 61. China Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 62. Japan Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 63. Korea Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 65. India Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 66. Australia Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 67. Germany Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 68. France Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 69. UK Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 70. Italy Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 71. Russia Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 72. Egypt Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 73. South Africa Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 74. Israel Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 75. Turkey Nonstructural Protein 4B Market Size 2026-2031 ($ millions)
Figure 76. Global Nonstructural Protein 4B Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Nonstructural Protein 4B Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Nonstructural Protein 4B Market Size 2026-2031 ($ millions)